Dylan M Marchione

9PUBLICATIONS
53CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Radiology and organ imagingMedical parasitology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 09, 2026
The conserved N-terminal SANT1-binding domain (SBD) of EZH2 regulates PRC2 activity.

Agata L Patriotis, Douglas W Barrows, Yadira Soto-Feliciano

|Apr 04, 2023
Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for IDH1-Mutated Acute Myeloid Leukemia.

Amir T Fathi, Haesook T Kim, Robert J Soiffer

|Oct 17, 2020
Histone H3.3 G34 mutations promote aberrant PRC2 activity and drive tumor progression.

Siddhant U Jain, Sima Khazaei, Dylan M Marchione

|May 04, 2020
Human chimeric antigen receptor macrophages for cancer immunotherapy.

Michael Klichinsky, Marco Ruella, Olga Shestova

|Jan 15, 2020
HYPERsol: High-Quality Data from Archival FFPE Tissue for Clinical Proteomics.

Dylan M Marchione, Ilyana Ilieva, Kyle Devins

Pageof 2